Your browser doesn't support javascript.
loading
Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India.
Sehrawat, Amit; Khanna, Mridul; Kayal, Smita; Sundriyal, Deepak; Tiwari, Shraddha; Cyriac, Sunu; Ravishankaran, Praveen; Raphael, Jomon; Mathew, Dominic; Panda, Soumya Surath; Moharana, Laltendu; Mohanty, Sumit Subhadarshi; Mohanty, Swati Sucharita; Philips, Ashwin; Jain, Deepak; Jeyaraj, Pamela; David, Parvez Haque; Patil, Jaineet; Saju, S V; Rathnam, Krishnakumar; Sharma, Neha; Dheva, Kaaviya; Jinkala, Sree Rekha; Raja, Kalyarasaran; Penumadu, Prasanth; Ganesan, Prasanth.
Affiliation
  • Sehrawat A; All India Institute of Medical Sciences, Rishikesh, India.
  • Khanna M; All India Institute of Medical Sciences, Rishikesh, India.
  • Kayal S; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Sundriyal D; All India Institute of Medical Sciences, Rishikesh, India.
  • Tiwari S; All India Institute of Medical Sciences, Rishikesh, India.
  • Cyriac S; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Ravishankaran P; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Raphael J; Amala Institute of Medical Sciences, Thrissur, India.
  • Mathew D; Amala Institute of Medical Sciences, Thrissur, India.
  • Panda SS; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Moharana L; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Mohanty SS; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Mohanty SS; IMS and SUM Hospital, SOA University, Bhubaneswar, India.
  • Philips A; Christian Medical College Hospital, Ludhiana, India.
  • Jain D; Christian Medical College Hospital, Ludhiana, India.
  • Jeyaraj P; Christian Medical College Hospital, Ludhiana, India.
  • David PH; Christian Medical College Hospital, Ludhiana, India.
  • Patil J; Christian Medical College Hospital, Ludhiana, India.
  • Saju SV; Meenakshi Mission Hospital and Research Centre, Madurai, India.
  • Rathnam K; Meenakshi Mission Hospital and Research Centre, Madurai, India.
  • Sharma N; ICMR-NCDIR, Bengaluru, India.
  • Dheva K; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Jinkala SR; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Raja K; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Penumadu P; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
  • Ganesan P; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
JCO Glob Oncol ; 10: e2300225, 2024 May.
Article in En | MEDLINE | ID: mdl-38754051
ABSTRACT

PURPOSE:

Colorectal cancer (CRC) in young adults is a rising concern in developing countries such as India. This study investigates clinicopathologic profiles, treatment patterns, and outcomes of CRC in young adults, focusing on adolescent and young adult (AYA) CRC in a low- and middle-income country (LMIC).

METHODS:

A retrospective registry study from January 2018 to December 2020 involved 126 young adults (age 40 years and younger) with CRC. Patient demographics, clinical features, tumor characteristics, treatment modalities, and survival outcomes were analyzed after obtaining institutional ethics committees' approval.

RESULTS:

Among 126 AYA patients, 62.70% had colon cancer and 37.30% had rectal cancer. Most patients (67%) were age 30-39 years, with no significant gender predisposition. Females had higher metastatic burden. Abdominal pain with obstruction features was common. Adenocarcinoma (65%) with signet ring differentiation (26%) suggested aggressive behavior. Limited access to molecular testing hindered mutation identification. Capecitabine-based chemotherapy was favored because of logistical constraints. Adjuvant therapy showed comparable recurrence-free survival in young adults and older patients. For localized colon cancer, the 2-year median progression-free survival was 74%, and for localized rectal cancer, it was 18 months. Palliative therapy resulted in a median overall survival of 33 months (95% CI, 18 to 47). Limited access to targeted agents affected treatment options, with only 27.5% of patients with metastatic disease receiving them. Chemotherapy was generally well tolerated, with hematologic side effect being most common.

CONCLUSION:

This collaborative study in an LMIC offers crucial insights into CRC in AYA patients in India. Differences in disease characteristics, treatment patterns, and limited access to targeted agents highlight the need for further research and resource allocation to improve outcomes in this population.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: JCO Glob Oncol Year: 2024 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: JCO Glob Oncol Year: 2024 Document type: Article Affiliation country: India
...